Log In
BCIQ
Print this Print this
 

BAY 2306001, IONIS-FXIRx, ISIS 416858 (formerly ISIS-FXIRx)

Also known as: Factor XI antisense inhibitor

  Manage Alerts
Collapse Summary General Information
Company Ionis Pharmaceuticals Inc.
DescriptionFactor XI antisense inhibitor
Molecular Target Factor XI
Mechanism of ActionAntisense therapy
Therapeutic ModalityNucleic acid: Linear RNA: Antisense

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$475.0M

$100.0M

$375.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/04/2015

$475.0M

$100.0M

$375.0M

Get a free BioCentury trial today